Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 1
1913 1
1914 4
1916 1
1919 1
1925 1
1930 1
1938 1
1940 1
1941 1
1946 8
1947 2
1948 2
1949 2
1950 2
1951 1
1952 3
1953 4
1954 2
1955 4
1956 3
1957 2
1958 3
1959 6
1960 6
1961 6
1962 7
1963 1
1964 4
1965 16
1966 10
1967 7
1968 7
1969 5
1970 7
1971 6
1972 9
1973 13
1974 9
1975 5
1976 14
1977 11
1978 12
1979 11
1980 14
1981 14
1982 19
1983 19
1984 24
1985 21
1986 12
1987 28
1988 12
1989 23
1990 23
1991 25
1992 35
1993 37
1994 31
1995 38
1996 19
1997 27
1998 41
1999 42
2000 40
2001 61
2002 60
2003 76
2004 90
2005 93
2006 93
2007 106
2008 103
2009 90
2010 94
2011 99
2012 115
2013 97
2014 106
2015 120
2016 154
2017 110
2018 108
2019 84
2020 105
2021 97
2022 111
2023 93

Text availability

Article attribute

Article type

Publication date

Search Results

2,812 results

Results by year

Filters applied: . Clear all
Page 1
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.
Ye L, Park JJ, Peng L, Yang Q, Chow RD, Dong MB, Lam SZ, Guo J, Tang E, Zhang Y, Wang G, Dai X, Du Y, Kim HR, Cao H, Errami Y, Clark P, Bersenev A, Montgomery RR, Chen S. Ye L, et al. Among authors: clark p. Cell Metab. 2022 Apr 5;34(4):595-614.e14. doi: 10.1016/j.cmet.2022.02.009. Epub 2022 Mar 10. Cell Metab. 2022. PMID: 35276062 Free PMC article.
Massively parallel knock-in engineering of human T cells.
Dai X, Park JJ, Du Y, Na Z, Lam SZ, Chow RD, Renauer PA, Gu J, Xin S, Chu Z, Liao C, Clark P, Zhao H, Slavoff S, Chen S. Dai X, et al. Among authors: clark p. Nat Biotechnol. 2023 Sep;41(9):1239-1255. doi: 10.1038/s41587-022-01639-x. Epub 2023 Jan 26. Nat Biotechnol. 2023. PMID: 36702900
Bone Mineral Density After Transitioning From Denosumab to Alendronate.
Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, Huang S, Stad RK. Kendler D, et al. Among authors: clark p. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e255-64. doi: 10.1210/clinem/dgz095. J Clin Endocrinol Metab. 2020. PMID: 31665314 Free PMC article. Clinical Trial.
Proteins in the cell.
Clark PL. Clark PL. Protein Sci. 2019 Jul;28(7):1175-1176. doi: 10.1002/pro.3665. Protein Sci. 2019. PMID: 31152461 Free PMC article. No abstract available.
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis.
Jou E, Rodriguez-Rodriguez N, Ferreira AF, Jolin HE, Clark PA, Sawmynaden K, Ko M, Murphy JE, Mannion J, Ward C, Matthews DJ, Buczacki SJA, McKenzie ANJ. Jou E, et al. Among authors: clark pa. Sci Immunol. 2022 Jun 3;7(72):eabn0175. doi: 10.1126/sciimmunol.abn0175. Epub 2022 Jun 3. Sci Immunol. 2022. PMID: 35658010 Free PMC article.
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Warrick JI, Hu W, Yamashita H, Walter V, Shuman L, Craig JM, Gellert LL, Castro MAA, Robertson AG, Kuo F, Ostrovnaya I, Sarungbam J, Chen YB, Gopalan A, Sirintrapun SJ, Fine SW, Tickoo SK, Kim K, Thomas J, Karan N, Gao SP, Clinton TN, Lenis AT, Chan TA, Chen Z, Rao M, Hollman TJ, Li Y, Socci ND, Chavan S, Viale A, Mohibullah N, Bochner BH, Pietzak EJ, Teo MY, Iyer G, Rosenberg JE, Bajorin DF, Kaag M, Merrill SB, Joshi M, Adam R, Taylor JA 3rd, Clark PE, Raman JD, Reuter VE, Chen Y, Funt SA, Solit DB, DeGraff DJ, Al-Ahmadie HA. Warrick JI, et al. Among authors: clark pe. Nat Commun. 2022 Nov 2;13(1):6575. doi: 10.1038/s41467-022-34251-3. Nat Commun. 2022. PMID: 36323682 Free PMC article.
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
Perdigoto AL, Preston-Hurlburt P, Clark P, Long SA, Linsley PS, Harris KM, Gitelman SE, Greenbaum CJ, Gottlieb PA, Hagopian W, Woodwyk A, Dziura J, Herold KC; Immune Tolerance Network. Perdigoto AL, et al. Among authors: clark p. Diabetologia. 2019 Apr;62(4):655-664. doi: 10.1007/s00125-018-4786-9. Epub 2018 Dec 19. Diabetologia. 2019. PMID: 30569273 Free PMC article.
Reply by Authors.
Rodriguez-Homs M, Pessoa RR, Konety B, Gershman B, Clark PE, Bronsert M, Flaig TW, Tevis SE, Lloyd G, Morrison JC, Kim SP. Rodriguez-Homs M, et al. Among authors: clark pe. Urol Pract. 2022 Nov;9(6):559. doi: 10.1097/UPJ.0000000000000346.03. Epub 2022 Sep 6. Urol Pract. 2022. PMID: 37145830 No abstract available.
2,812 results